DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on August 24, 2005; DOI: 10.1124/dmd.105.003673


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.003673v1
dmd.105.003673v2
33/12/1777    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Ming Hu
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Hu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Hu, M.


Received for publication January 25, 2005.
Revised August 23, 2005.
Accepted for publication August 23, 2005.

Disposition of Flavonoids via Recycling: Comparison of Intestinal versus Hepatic Disposition

Jun Chen 1, Stephen Wang 1, Xiaobin Jia 1, Susan Bajimaya 1, Vincent Tam 1, Ming Hu 1*

1 University of Houston

* Address correspondence to: E-mail: mhu{at}uh.edu

Abstract

The purpose of this study was to compare intestinal versus hepatic disposition of six flavonoids in order to fully characterize their first-pass metabolism. The perfused rat intestinal model and microsomes prepared from rat liver, duodenum, jejunum, ileum and colon were used. The results indicated that isoflavone (12.5 µM) glucuronidation was highly variable among different microsomes prepared from liver or intestine. Comparing to liver metabolism, the intestinal metabolism had higher Km values (>2 folds). Likewise, the hepatic intrinsic clearance (IC, or a ratio of Vmax/Km) values of isoflavones were generally higher than their intestinal IC values (200%-2000% higher), except for prunetin, whose jejunal IC value was 50% higher than its hepatic IC. When comparing intestinal metabolism, the results showed that intestinal metabolism rates and Vmax values of isoflavones were less when an additional A-ring electron-donating group was absent (i.e., daidzein and formononetin). In rat perfusion model using the whole small intestine, genistein (10 µM) was well absorbed (77% or 352 nmol/120 min). The first-pass metabolism of genistein was extensive, with 40% of absorbed genistein excreted as conjugated metabolites into the intestinal lumen. In contrast, the bile excretion of genistein conjugates was much less (6.4% of absorbed genistein). In conclusion, intestinal glucuronidation is slower in isoflavones without an additional A-ring substitution. Perfusion studies suggest that intestine is the main organ for genistein glucuronide formation and excretion in rats, and may serve as its main first-pass metabolism organ.


Key words: absorption, enzyme kinetics, excretion, in vitro-in vivo prediction, intestinal transport, phase II drug metabolism, structure-activity relationships, UDP glucuronyltransferases


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. Enokizono, H. Kusuhara, and Y. Sugiyama
Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens
Mol. Pharmacol., October 1, 2007; 72(4): 967 - 975.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. W. J. Wang, J. Chen, X. Jia, V. H. Tam, and M. Hu
Disposition of Flavonoids via Enteric Recycling: Structural Effects and Lack of Correlations between in Vitro and in Situ Metabolic Properties
Drug Metab. Dispos., November 1, 2006; 34(11): 1837 - 1848.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.